BRPI0706679A2 - métodos e kits adequados para prevenir e para tratar doença renal crÈnica em um felino, composição, meios para comunicar informação, uso de uma composição, e. método para diminuir o nìvel de soro de creatinina em um animal - Google Patents
métodos e kits adequados para prevenir e para tratar doença renal crÈnica em um felino, composição, meios para comunicar informação, uso de uma composição, e. método para diminuir o nìvel de soro de creatinina em um animal Download PDFInfo
- Publication number
- BRPI0706679A2 BRPI0706679A2 BRPI0706679-1A BRPI0706679A BRPI0706679A2 BR PI0706679 A2 BRPI0706679 A2 BR PI0706679A2 BR PI0706679 A BRPI0706679 A BR PI0706679A BR PI0706679 A2 BRPI0706679 A2 BR PI0706679A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- feline
- protein
- dry matter
- matter basis
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 321
- 241000282324 Felis Species 0.000 title claims abstract description 245
- 208000020832 chronic kidney disease Diseases 0.000 title claims abstract description 188
- 238000000034 method Methods 0.000 title claims abstract description 75
- 210000002966 serum Anatomy 0.000 title claims abstract description 23
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 title claims description 36
- 229940109239 creatinine Drugs 0.000 title claims description 18
- 241001465754 Metazoa Species 0.000 title claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 210
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 210
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims abstract description 82
- 208000017169 kidney disease Diseases 0.000 claims abstract description 16
- 230000001684 chronic effect Effects 0.000 claims abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 7
- 230000002265 prevention Effects 0.000 claims abstract description 7
- 201000010099 disease Diseases 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 50
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 42
- 229910052698 phosphorus Inorganic materials 0.000 claims description 42
- 239000011574 phosphorus Substances 0.000 claims description 41
- 239000004615 ingredient Substances 0.000 claims description 37
- 229910052708 sodium Inorganic materials 0.000 claims description 30
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 29
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 29
- 239000011734 sodium Substances 0.000 claims description 29
- 239000011591 potassium Substances 0.000 claims description 28
- 229910052700 potassium Inorganic materials 0.000 claims description 28
- 235000013305 food Nutrition 0.000 claims description 20
- 230000003247 decreasing effect Effects 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 238000003860 storage Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- 208000017667 Chronic Disease Diseases 0.000 claims description 3
- 208000010717 cat disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 208000022831 chronic renal failure syndrome Diseases 0.000 abstract description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 178
- 241000282326 Felis catus Species 0.000 description 40
- 235000005911 diet Nutrition 0.000 description 13
- 230000037213 diet Effects 0.000 description 12
- 235000013312 flour Nutrition 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 239000012141 concentrate Substances 0.000 description 7
- 230000003907 kidney function Effects 0.000 description 7
- 235000013311 vegetables Nutrition 0.000 description 7
- 108010068370 Glutens Proteins 0.000 description 6
- 208000001647 Renal Insufficiency Diseases 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 235000021312 gluten Nutrition 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 201000006370 kidney failure Diseases 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 235000015277 pork Nutrition 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 208000037157 Azotemia Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000024924 glomerular filtration Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 206010062237 Renal impairment Diseases 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- XPCFTKFZXHTYIP-PMACEKPBSA-N Benazepril Chemical compound C([C@@H](C(=O)OCC)N[C@@H]1C(N(CC(O)=O)C2=CC=CC=C2CC1)=O)CC1=CC=CC=C1 XPCFTKFZXHTYIP-PMACEKPBSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000005770 Secondary Hyperparathyroidism Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 description 1
- 229960004005 amlodipine besylate Drugs 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 229940070021 anabolic steroids Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229960004530 benazepril Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 238000011862 kidney biopsy Methods 0.000 description 1
- 229940063711 lasix Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- IRQVJPHZDYMXNW-UHFFFAOYSA-N metoclopramide dihydrochloride monohydrate Chemical compound O.[Cl-].[Cl-].CC[NH+](CC)CCNC(=O)C1=CC(Cl)=C([NH3+])C=C1OC IRQVJPHZDYMXNW-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 229940080693 reglan Drugs 0.000 description 1
- 125000004436 sodium atom Chemical group 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000583 toxicological profile Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/22—Compounds of alkali metals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/26—Compounds containing phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76006806P | 2006-01-19 | 2006-01-19 | |
| US60/760,068 | 2006-01-19 | ||
| PCT/US2007/060773 WO2007084986A2 (en) | 2006-01-19 | 2007-01-19 | Compositions and methods for preventing or treating feline chronic kidney disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0706679A2 true BRPI0706679A2 (pt) | 2011-04-05 |
Family
ID=38163311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0706679-1A BRPI0706679A2 (pt) | 2006-01-19 | 2007-01-19 | métodos e kits adequados para prevenir e para tratar doença renal crÈnica em um felino, composição, meios para comunicar informação, uso de uma composição, e. método para diminuir o nìvel de soro de creatinina em um animal |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090275505A1 (https=) |
| EP (2) | EP1981354B1 (https=) |
| JP (1) | JP2009523827A (https=) |
| CN (1) | CN101374421A (https=) |
| AU (2) | AU2007205825B2 (https=) |
| BR (1) | BRPI0706679A2 (https=) |
| CA (1) | CA2636039C (https=) |
| RU (1) | RU2404684C2 (https=) |
| WO (1) | WO2007084986A2 (https=) |
| ZA (1) | ZA200805958B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501223B2 (en) | 2003-06-20 | 2013-08-06 | Hill's Pet Nutrition, Inc. | Methods for dietary management of cats to avoid hyperthyroidism |
| CN101374420B (zh) * | 2006-01-26 | 2016-11-09 | 希尔氏宠物营养品公司 | 治疗猫科动物的甲状腺机能亢进的方法和组合物 |
| JP5637683B2 (ja) * | 2006-05-12 | 2014-12-10 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 甲状腺機能亢進症のネコ科動物において慢性腎不全を予防又は治療するための組成物及び方法 |
| BRPI0713634A2 (pt) * | 2006-07-03 | 2012-10-23 | Hills Pet Nutrition Inc | uso de iodo ou selênio, composição e kit para prevenir e/ou tratar uma doença cardiovascular em um felino com hipertiroidismo, e, meio para comunicar informação |
| AU2010343129B2 (en) * | 2009-12-29 | 2013-05-16 | Hill's Pet Nutrition, Inc. | Compositions including pyruvate for companion animals and methods of use thereof |
| WO2014092158A1 (ja) * | 2012-12-13 | 2014-06-19 | ユニ・チャーム株式会社 | ペットフード |
| FR3002735B1 (fr) | 2013-03-04 | 2015-07-03 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
| FR3002736B1 (fr) | 2013-03-04 | 2015-06-26 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
| US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
| AU2014225786B2 (en) | 2013-03-08 | 2017-10-12 | Axiom Foods, Inc. | Rice protein supplements |
| WO2015069212A1 (en) | 2013-11-05 | 2015-05-14 | Hill's Pet Nutrition, Inc. | Palatability enhancers for foods designed for dogs and cats with renal insufficiency |
| WO2016152706A1 (ja) * | 2015-03-20 | 2016-09-29 | 株式会社明治 | 腎機能改善剤 |
| WO2018209131A1 (en) | 2017-05-12 | 2018-11-15 | Axiom Foods, Inc. | Rice products and systems and methods for making thereof |
| EP3917329A4 (en) * | 2019-02-01 | 2022-11-30 | Mars, Incorporated | CAT FOOD COMPOSITION |
| CN110870512A (zh) * | 2019-04-10 | 2020-03-10 | 张璐 | 猫慢性肾脏疾病饮食配方 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04210639A (ja) * | 1990-11-30 | 1992-07-31 | Dainippon Pharmaceut Co Ltd | 電解質含量を低減化した食物繊維 |
| JPH06197715A (ja) * | 1992-03-16 | 1994-07-19 | Kissei Pharmaceut Co Ltd | たんぱく質調整そば |
| US6039952A (en) * | 1997-10-22 | 2000-03-21 | The Iams Company | Composition and method for improving clinical signs in animals with renal disease |
| JPH11243879A (ja) * | 1998-03-04 | 1999-09-14 | Honke Matsuura Shuzojo:Kk | 低リン米の製造方法およびそれによって得られる低リン、低タンパク、低カリウム米 |
| ES2203245T3 (es) * | 1998-09-02 | 2004-04-01 | Heska Corporation | Metodo y composicion para proteger un carnivoro obligado de una enfermedad de metabolismo anormal de carbohidratos. |
| JP2002204668A (ja) * | 2001-01-11 | 2002-07-23 | Q P Corp | 栄養組成物 |
| JP2003334009A (ja) * | 2002-05-20 | 2003-11-25 | Kissei Pharmaceut Co Ltd | 成分調整餅様食品 |
| US8501223B2 (en) | 2003-06-20 | 2013-08-06 | Hill's Pet Nutrition, Inc. | Methods for dietary management of cats to avoid hyperthyroidism |
| ES2359818T3 (es) * | 2003-06-20 | 2011-05-27 | Hill's Pet Nutrition, Inc. | Métodos para hipertiroidismo en un gato y composición que comprende yodo limitado. |
| JP5637683B2 (ja) * | 2006-05-12 | 2014-12-10 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 甲状腺機能亢進症のネコ科動物において慢性腎不全を予防又は治療するための組成物及び方法 |
-
2007
- 2007-01-19 BR BRPI0706679-1A patent/BRPI0706679A2/pt not_active IP Right Cessation
- 2007-01-19 AU AU2007205825A patent/AU2007205825B2/en not_active Ceased
- 2007-01-19 CN CNA2007800032392A patent/CN101374421A/zh active Pending
- 2007-01-19 EP EP07717323.5A patent/EP1981354B1/en active Active
- 2007-01-19 RU RU2008133986/13A patent/RU2404684C2/ru not_active IP Right Cessation
- 2007-01-19 EP EP12158853.7A patent/EP2462815B1/en active Active
- 2007-01-19 WO PCT/US2007/060773 patent/WO2007084986A2/en not_active Ceased
- 2007-01-19 JP JP2008551549A patent/JP2009523827A/ja active Pending
- 2007-01-19 CA CA2636039A patent/CA2636039C/en not_active Expired - Fee Related
- 2007-01-19 US US12/161,583 patent/US20090275505A1/en not_active Abandoned
-
2008
- 2008-07-08 ZA ZA2008/05958A patent/ZA200805958B/en unknown
-
2011
- 2011-03-18 AU AU2011201233A patent/AU2011201233B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011201233B2 (en) | 2011-08-04 |
| EP1981354B1 (en) | 2017-11-15 |
| JP2009523827A (ja) | 2009-06-25 |
| WO2007084986A3 (en) | 2007-11-22 |
| CA2636039A1 (en) | 2007-07-26 |
| RU2008133986A (ru) | 2010-02-27 |
| EP1981354A2 (en) | 2008-10-22 |
| RU2404684C2 (ru) | 2010-11-27 |
| CA2636039C (en) | 2013-03-19 |
| EP2462815A1 (en) | 2012-06-13 |
| WO2007084986A2 (en) | 2007-07-26 |
| AU2007205825A1 (en) | 2007-07-26 |
| CN101374421A (zh) | 2009-02-25 |
| AU2011201233A1 (en) | 2011-04-07 |
| EP2462815B1 (en) | 2020-11-11 |
| ZA200805958B (en) | 2014-09-25 |
| AU2007205825B2 (en) | 2011-05-26 |
| US20090275505A1 (en) | 2009-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0706679A2 (pt) | métodos e kits adequados para prevenir e para tratar doença renal crÈnica em um felino, composição, meios para comunicar informação, uso de uma composição, e. método para diminuir o nìvel de soro de creatinina em um animal | |
| CN101287460B (zh) | 预防和治疗肾病的组合物 | |
| RU2411746C2 (ru) | Композиция (варианты) и способ (варианты) предотвращения или лечения хронической почечной недостаточности у кошачьих с гипертироидизмом | |
| JP2015007093A (ja) | 腎臓機能を改善する組成物および方法 | |
| AU2011201051B2 (en) | Methods and compositions for treating feline hyperthyroidism | |
| BRPI0610731A2 (pt) | composição, método para evitar ou tratar doença do rim, conjunto para a administração de uma composição de prevenção ou tratamento de doenças do rim ao paciente, método para a promoção da saúde do rim, meios para a comunicação de informação a respeito ou instruções para a mistura e a administração de uma ou mais das composições, componentes da composição, composições alimentìcias, ingredientes alimentìcios, e drogas renais, e para a utilização de dispositivos de diagnósticos renal da presente invenção, e, uso de uma composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 10, 11, 13 E 25 DA LPI |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2394 DE 22-11-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A23K 50/40 (2016.01), A23K 10/30 (2016.01), A23K 2 |